Genital Neoplasms, Female  >>  Lynparza (olaparib) 
Welcome,         Profile    Billing    Logout  

1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lynparza (olaparib) / Merck (MSD), AstraZeneca
NCT03063710: Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan

No Longer Available
N/A
Japan
olaparib
AstraZeneca
PSR Ovarian Cancer With a BRCA Mutation
 
 

Download Options